Kimiafaam Pharmaceutical Company

Introduction to Kimiafaam Pharmaceutical Company

Kimiafaam Pharmaceutical Company has always based its progressive goals on producing high-quality products at reasonable prices, and in this regard, it considers its greatest achievement to be the offering of quality products and extensive services to its customers.Kimiafaam is among the active and pioneering entities in the field of veterinary medicines, various disinfectants, and cosmetic and hygiene products, having started its operations in 1993. In addition to offering high-quality and competitively priced therapeutic products for livestock, poultry, and aquaculture, as well as disinfectants and cosmetic hygiene products, the company provides extensive informational and educational services to its customers.Kimiafaam has consistently prioritized quality in the production and supply of diverse products, aiming to deliver entirely suitable products through the expertise of experienced consultants, specialists, and cutting-edge global scientific research. The variety of products tailored to different regions and conditions is a testament to this commitment.
The technical team’s ongoing support for the buyers of its products over the years has provided consumers with confidence, reflecting the company’s assurance in the quality of its products.

Raw Materials and Quality

Before the revolution, veterinary medicines in Iran were primarily trade-driven, with the majority of consumed drugs being imported. Only a small percentage of required drugs were produced domestically, and these were mostly ordinary and simple medications. In recent years, despite numerous challenges, Iran’s veterinary pharmaceutical industry has achieved significant milestones, to the extent that a large portion of the drugs used in the veterinary sector is now produced domestically by Iranian pharmaceutical factories.The knowledge and technology of Iranian pharmaceutical companies are not inferior to those of drug-exporting countries. However, what impacts the quality difference of some drugs is the raw materials used in their production. When high-quality raw materials are used in drug manufacturing, the resulting products are undoubtedly of high quality and have efficacy comparable to their foreign counterparts. However, if substandard raw materials are used, it leads to a decline in quality. Since its establishment, Kimiafaam Pharmaceutical Company has consistently used high-quality raw materials from reputable European and North American manufacturers, such as Krka, Janssen, and others, which is evidenced by the satisfaction of consumers with the quality of the company’s products.

Pharmacopeia tests represent a minimum standard, not an optimal one, and most quality control laboratories in pharmaceutical manufacturing facilities settle for this minimum standard. However, at Kimiafaam Pharmaceutical Company, to achieve maximum shelf life and enhance the speed of drug efficacy, the optimal amount of active ingredients is consistently used. Furthermore, regulatory bodies overseeing drug production in Iran define quality within an “acceptable” range, meaning that two identical drugs from different manufacturers may fall at opposite ends of this standard—one at the highest level and another at the lowest. Kimiafaam Pharmaceutical Company’s policy in producing veterinary drugs has always been to adhere to the upper limit of this standard. This is why many clinicians, aware of this commitment, prefer to prescribe drugs produced by Kimiafaam.In addition to the factors mentioned above for drug production, the excipients added to drugs significantly affect their quality, absorption rate, and efficacy. A company aiming to reduce production costs may use lower-quality excipients, while a company prioritizing drug quality and consumer satisfaction, like Kimiafaam, uses higher-quality excipients that enhance the drug’s effectiveness. This has been established as a consistent practice in drug production at Kimiafaam.

International Certifications

The German DQS Institute is one of the largest and most reputable auditing organizations for granting international standards worldwide. With over 100 global standards in management and system processes, it is one of the leading companies in this field.Established in 1985 by the German Institute for Standardization (DIN) and the German Society for Quality (DGQ), DQS merged with the management systems division of Underwriters Laboratories in 2008, overseeing its operations globally. Headquartered in Frankfurt, Germany, DQS employs 2,500 auditors worldwide, with a primary mission of ensuring quality and management as an independent entity to enhance organizational performance, unlock their potential, and improve customer efficiency. The rigorous auditing standards of DQS, aligned with the latest global advancements and applied to major international companies, have made it challenging for companies in Iran to obtain certification from this Certification Body.With over 25 years of experience in producing veterinary drugs and human disinfectants, as well as a history of collaboration with leading international companies such as Janssen (Belgium), Sintofarm (Italy), Hipra (Spain), Krka (Slovenia), Calier (Spain), Kenzy (Canada), and holding exclusive representation for some BASF (Germany) raw materials, the Kimiafaam Pharmaceutical Group has proudly earned numerous global certifications from DQS, making it unparalleled in the Middle Eastern pharmaceutical industry.After decades of relentless effort, the Kimiafaam Pharmaceutical Group has become a leader in Iran’s livestock and poultry pharmaceutical industry by obtaining the following standards from DQS Germany.

These standards include:

ISO 9001:2015 Standard

Quality Management System

This standard, as one of the general standards in organizational quality, encompasses everything from evaluating the quality of incoming raw materials and assessing suppliers to controlling production processes and final product quality checks before storage and delivery to customers.

ISO 14001:2015 Standard

Environmental Management System

This standard requires companies, certified by environmental organizations, to annually measure the compliance of their processes with environmental standards (air, water, soil, etc.) to determine the level of pollution or non-compliance with these criteria.

ISO 18001:2007 Standard

Occupational Health and Safety Management System

This section involves annual assessments by companies approved by the labor authority to measure the organization’s adherence to occupational health and safety standards defined for the pharmaceutical industry.

ISO 10002:2014 Standard

Customer Complaint Management System

This standard pertains to the precise and fair management and handling of opinions, suggestions, and complaints from all customers regarding the organization’s services and products.

ISO 10004:2012 Standard

Customer Satisfaction Management System

This standard involves the regular and periodic measurement of customer satisfaction with the quality of the organization’s products and services, as well as addressing customer dissatisfaction when necessary.

Workplace Organization System

This system entails requirements for organizing, cleaning, maintaining order, and standardizing discipline across all administrative and production sections of an organization.

GMP

Good Manufacturing Practices

These requirements align with the quality management system standards, focusing on ensuring the production of high-quality products while emphasizing compliance with building, equipment, production, and storage standards suitable for the class of pharmaceutical product manufacturing.

GLP

Good Laboratory Practices

These requirements are a fundamental aspect of the pharmaceutical industry, ensuring compliance with physical and documentation standards to guarantee the quality determination of raw materials needed for the product, quality control during production, and the quality of the final product ready for delivery to customers.

GDP

Good Distribution Practices

These requirements include maintaining a modern and equipped transportation fleet, adhering to Good Hygiene Practices (GHP) suitable for the transport and storage conditions of pharmaceuticals, and ensuring warehouses are equipped with proper layout, storage conditions (heating and cooling equipment), loading and unloading machinery (forklifts, stackers), as well as trained personnel and computerized systems for tracking and recording goods. Only a few companies have successfully met and implemented GDP requirements, and with pride, the Kimiafaam Pharmaceutical Group (Kimiapakhsh Faam Company) has implemented these requirements and obtained this certification.

IMS

Integrated Management System

اThese requirements encompass compliance with three standards: the Quality Management System, the Environmental Management System, and the Occupational Health and Safety Management System, ensuring integration, precise adherence, and automation among these standards.

IQNET

Global Quality Network

This organization, as an independent entity in the field of quality, recognizes compliance with the set of requirements and criteria for the ISO 9001, ISO 14001, and OHSAS 18001 standards. For this reason, it awards certifications for ISO 9001, ISO 14001, and OHSAS 18001 to signify the maximum alignment of an organization’s processes with these standards.

Collaborative Laboratory with the Standards Organization

Confirmation from the Standards Organization on the validity and documentation of all tests conducted in the Kimiafaam Pharmaceutical Laboratory for presentation to customers and organizations in accordance with the SCOP approved by this organization.